黑色素瘤临床试验招募信息（全球在招）

这里汇总了全球正在招募患者的 黑色素瘤（国际通用名 melanoma）新药临床试验，包含试验分期、招募状态、开展国家和研究团队联系方式，全部以中文呈现。数据实时来自全球最大的临床试验注册库 ClinicalTrials.gov。本页同时覆盖恶性黑色素瘤等说法。

正在招募的黑色素瘤新药试验

• A Phase II Trial of LM103 in Advanced Melanoma

  II 期招募中中国NCT07310784

• A Study to Assess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3

  不适用招募中美国澳大利亚NCT06887348

• Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study

  IV 期招募中美国NCT07405086

• Navigation Intervention for Adolescent and Young Adult Cancer Survivors

  不适用招募中美国NCT07406087

• Nilotinib Plus Dabrafenib/Trametinib or Encorafenib/Binimetinib in Metastatic Melanoma

  I 期招募中美国NCT04903119

• A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors

  I 期 / II 期招募中美国澳大利亚加拿大德国NCT04895709

• Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial

  不适用招募中美国NCT04693377

• Follow-up of Patients With Uveal Melanoma Adapted to the Risk of Relapse (SALOME)

  不适用招募中法国NCT04424719

• Immunotherapy or Targeted Therapy With or Without Stereotactic Radiosurgery for Patients With Brain Metastases From Melanoma or Non-small Cell Lung Cancer

  III 期招募中意大利Netherlands西班牙SwitzerlandNCT05522660

• Study of Cemiplimab Plus Ziv-Aflibercept for Subjects With Metastatic Uveal Melanoma

  II 期招募中美国NCT06121180

• Studying Off Label Insurance Coverage for Patients With Cutaneous Cancers a "Filter" Observational Study

  不适用招募中美国NCT07215988

• Symptom Management and Survivorship Plus Coaching for Advanced Cancer Survivors and Their Caregivers

  不适用招募中美国NCT07415564